With regard to tumour cells, (high level) CD95L expression might not only protect the tumour by inducing apoptosis in activated ("CD95-sensitive") tumour infiltrating cells, a mechanism that was referred to as 'tumor counterattack' [78], but could also block the activation of potentially tumour-reactive primary T cells for instance during metastatic spreading. Here, FASLG is linked to neoplasm.